AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 149 filers reported holding AUDENTES THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,336,000 | +183.1% | 22,329 | +33.0% | 0.00% | +200.0% |
| Q3 2019 | $472,000 | -25.8% | 16,794 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $636,000 | +8.3% | 16,794 | +11.6% | 0.00% | 0.0% |
| Q1 2019 | $587,000 | +82.9% | 15,046 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $321,000 | -34.5% | 15,046 | +21.5% | 0.00% | 0.0% |
| Q3 2018 | $490,000 | +3.6% | 12,385 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $473,000 | +100.4% | 12,385 | +57.7% | 0.00% | 0.0% |
| Q1 2018 | $236,000 | +12.9% | 7,852 | +17.1% | 0.00% | – |
| Q4 2017 | $209,000 | – | 6,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,806,832 | $50,862,321,000 | 38.71% |
| Casdin Capital, LLC | 400,000 | $11,204,000 | 3.16% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,525,410 | $42,727,000 | 1.92% |
| Opaleye Management Inc. | 180,000 | $5,041,000 | 1.78% |
| Redmile Group, LLC | 1,289,332 | $36,114,000 | 1.78% |
| Cormorant Asset Management, LP | 323,545 | $9,062,000 | 1.60% |
| Orbimed Advisors | 4,129,638 | $115,671,000 | 1.10% |
| Perceptive Advisors | 1,562,618 | $43,770,000 | 0.84% |
| Rock Springs Capital Management LP | 525,000 | $14,705,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,661,000 | 0.38% |